DOMH Insider Trading

Insider Ownership Percentage: 9.74%
Insider Buying (Last 12 Months): $390,861.36
Insider Selling (Last 12 Months): $0.00

Dominari Insider Trading History Chart

This chart shows the insider buying and selling history at Dominari by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Dominari Share Price & Price History

Current Price: $2.14
Price Change: Price Increase of +0.05 (2.39%)
As of 05/17/2024 01:00 AM ET

This chart shows the closing price history over time for DOMH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Dominari Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/8/2024Kyle Michael WoolPresidentBuy8,500$2.99$25,415.0022,750View SEC Filing Icon  
4/4/2024Anthony HayesCEOBuy3,944$2.62$10,333.28102,748View SEC Filing Icon  
4/4/2024Kyle Michael WoolPresidentBuy19,000$2.87$54,530.0018,500View SEC Filing Icon  
12/26/2023Christopher Franklin DevallCOOBuy7,000$2.55$17,850.0030,033View SEC Filing Icon  
12/26/2023Kyle Michael WoolPresidentBuy5,000$2.60$13,000.009,000View SEC Filing Icon  
12/26/2023Kyle Michael WoolPresidentBuy5,000$2.60$13,000.009,000View SEC Filing Icon  
12/20/2023Anthony HayesCEOBuy70,000$2.00$140,000.0098,804View SEC Filing Icon  
11/28/2023Christopher Franklin DevallCOOBuy1,000$2.26$2,260.0022,033View SEC Filing Icon  
11/24/2023Anthony HayesCEOBuy1,481$2.16$3,198.9624,804View SEC Filing Icon  
11/22/2023Anthony HayesCEOBuy1,323$2.09$2,765.0723,323View SEC Filing Icon  
11/16/2023Anthony HayesCEOBuy2,500$1.97$4,925.0022,000View SEC Filing Icon  
11/14/2023Anthony HayesCEOBuy2,500$1.93$4,825.0019,500View SEC Filing Icon  
9/20/2023Anthony HayesCEOBuy15,000$2.59$38,850.0017,000View SEC Filing Icon  
9/19/2023Kyle Michael WoolDirectorBuy2,000$2.55$5,100.006,000View SEC Filing Icon  
9/13/2023Anthony HayesCEOBuy2,000$2.75$5,500.002,000View SEC Filing Icon  
9/11/2023Kyle Michael WoolDirectorBuy2,000$2.82$5,640.002,000View SEC Filing Icon  
8/25/2023Kyle Michael WoolDirectorBuy2,000$2.90$5,800.00818,858View SEC Filing Icon  
8/23/2023Anthony HayesCEOBuy2,000$2.86$5,720.00218,506View SEC Filing Icon  
8/21/2023Kyle Michael WoolDirectorBuy1,000$2.99$2,990.00816,858View SEC Filing Icon  
8/18/2023Kyle Michael WoolDirectorBuy1,369$2.95$4,038.55815,858View SEC Filing Icon  
8/16/2023Anthony HayesCEOBuy2,000$2.94$5,880.00216,506View SEC Filing Icon  
8/14/2023Kyle Michael WoolDirectorBuy2,000$3.00$6,000.00814,489View SEC Filing Icon  
6/13/2023Anthony HayesCEOBuy506$2.89$1,462.34213,187View SEC Filing Icon  
6/8/2023Kyle Michael WoolDirectorBuy424$2.59$1,098.16281,274View SEC Filing Icon  
5/30/2023Kyle Michael WoolDirectorBuy2,000$2.59$5,180.00280,850View SEC Filing Icon  
5/24/2023Anthony HayesCEOBuy2,000$2.75$5,500.00212,681View SEC Filing Icon  
5/18/2023Christopher Franklin DevallCOOBuy1,500$2.94$4,410.0021,033View SEC Filing Icon  
5/18/2023Kyle Michael WoolDirectorBuy2,000$2.94$5,880.00278,792View SEC Filing Icon  
5/16/2023Anthony HayesCEOBuy2,000$2.77$5,540.00208,681View SEC Filing Icon  
4/5/2023Christopher Franklin DevallCOOBuy5,698$3.51$19,999.9819,533View SEC Filing Icon  
4/4/2023Anthony HayesCEOBuy30,000$3.44$103,200.00206,681View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Dominari (NASDAQ:DOMH)

42.48% of Dominari stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Dominari logo
Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.
Read More on Dominari

Today's Range

Now: $2.14
Low: $2.02
High: $2.26

50 Day Range

MA: $2.46
Low: $2.05
High: $3.14

52 Week Range

Now: $2.14
Low: $1.76
High: $3.40

Volume

4,610 shs

Average Volume

9,713 shs

Market Capitalization

$12.69 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92

Who are the company insiders with the largest holdings of Dominari?

Dominari's top insider investors include:
  1. Kyle Michael Wool (Director)
  2. Anthony Hayes (CEO)
  3. Christopher Franklin Devall (COO)
  4. Kyle Michael Wool (President)
Learn More about top insider investors at Dominari.